According to a 2016 study, the mean price of insulin increased nearly 3-fold between 2002 and 2013.
Findings suggest that insulin resistance and deficiency may increase the risk of Alzheimer disease via their influence on brain function.
Current oral contraceptive products contain lower doses of estrogen than those used in the past, prompting reconsideration of risks and benefits.
Insulin resistance contributes to the increased risk of type 2 diabetes in individuals with polycystic ovary syndrome.
Although metformin has been studied in randomized trials as adjunctive therapy to insulin in individuals with type 1 diabetes, further investigation in the form of outcomes trials is necessary to assess risks vs benefits.
Endocrinologist Kevin M. Pantalone, DO, and psychiatrist Christian Kohler, MD, discuss the risk associated with the use of antipsychotic medications in individuals with type 2 diabetes.
Emerging evidence shows promise regarding the potential role of precision nutrition in the prevention and management of T2D. However, considerably more research is needed before this approach can be widely applied for these purposes.
Long-distance air travel presents numerous unique challenges for insulin-treated patients with diabetes. More accessible and adequate sources of guidance are needed to facilitate travel planning among this patient population.